Desara
Commercial- Indications
- Stress Urinary Incontinence
Company intelligence / Profile preview
Caldera Medical markets a portfolio of commercialized medical devices focused on women’s pelvic health. Their products include surgical implants for stress urinary incontinence and pelvic organ prolapse, as well as advanced minimally invasive hysteroscopic systems for diagnosis/treatment of uterine polyps and fibroids. The company has expanded its offerings through acquisitions such as UVision360’s LUMINELLE system and Atlantic Therapeutics’ Innovo device. No clinical trial results are reported; all major products are commercially available.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caldera Medical.